818. PRO
Session: Interactive Session: Clinical Controversies
Thursday, October 4, 2018: 2:25 PM
Room: W 2005-2024
Trish Perl, MD, MSc, FIDSA, FSHEA, Division of Infectious Diseases; Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX

Dr. Perl is currently the Chief of Infectious Diseases at UTSouthwestern Medical Center and the Jay P Sanford Professor of Medicine. She received her Bachelor of Arts and medical degree from the University of North Carolina at Chapel Hill and a Master of Science degree from McGill University in Montreal, Canada. She completed a residency in internal medicine at McGill University and a fellowship in infectious diseases and clinical epidemiology at the University of Iowa in Iowa City, Iowa. She rose through the ranks at Johns Hopkins University and Health System to become a Professor of Medicine and Pathology in the School of Medicine in Baltimore, Maryland, and in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She was the Hospital Epidemiologist of the Johns Hopkins Hospital between 1996 and 2011 and instrumental for building its reputation as a leader in the field and became the Senior Epidemiologist for The Johns Hopkins Health System. She is a clinician and enjoys seeing patients and has extensive practical and research experience in the field of healthcare associated infections and resistant and epidemiologically significant organisms and is recognized globally for her innovation and research in the field and the use of research knowledge in the healthcare setting. Dr. Perl is the former President of the Society of Hospital Epidemiologists of America (SHEA) and has served on advisory panels for the IOM, the CDC and WHO and been a consultant to the NIH and ARHQ. She was the Courage Fund Visiting Professor in 2008-10. An active researcher, Dr. Perl has been a principal and co-principal investigator on multiple studies funded by the CDC, the Veteran’s Affairs Administration over the years. She was the PI for the CDC EpiCenter grant at JHU between 2002 and 2010. She has authored or coauthored over 300 peer-reviewed articles. In addition, she has written multiple chapters and contributed to guidelines and policies relevant to healthcare associated infections at the institutional, state and federal level. She has been asked to help with management of international outbreaks including SARS and MERS CoV and consults with international governments on guideline development and strategies to prevent healthcare associated infections and antimicrobial resistance. She is currently on the Board of Directors for the IDSA.


Disclosures:

T. Perl, None

See more of: Clinical Controversies
See more of: Interactive Session
Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.